Patient Pathfinder: Clinical Trials
Clinical Trials for Multiple Myeloma
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 515 active Multiple Myeloma trials
MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) Survey
Study Type: Observational
Trial of Carfilzomib, Lenalidomide, Dexamethasone Versus Lenalidomide Alone After Stem-cell Transplant for Multiple Myeloma
Study Type: Interventional Phase 3
Velcade and Lenalidomide in Patients With Relapsed AML and MDS After Allogeneic Stem Cell Transplantation
Study Type: Interventional Phase 1
Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib
Study Type: Observational
Carfilzomib, Lenalidomide, and Dexamethasone Versus Bortezomib, Lenalidomide and Dexamethasone (KRd vs. VRd) in Patients With Newly Diagnosed Multiple Myeloma (COBRA)
Study Type: Interventional Phase 3
Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
Study Type: Interventional Phase 3
Busulfan, Melphalan, Escalating Carfilzomib Conditioning Auto Stem Cell Transplantation for Multiple Myeloma (MM)
Study Type: Interventional Phase 1
The Efficacy and Safety of SCTA01 in Hospitalized Patients With Severe COVID-19
Study Type: Interventional Phase 2
There are 515 active Multiple Myeloma trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now